DSIP and GLP-1: Does this 'sleepy girl' stack actually work?

What did @simplykieshhh actually say?

Honestly? Not much. The transcript provided is just the word "look" repeated over a hundred times, which means the substantive claims here come entirely from the caption and hashtags, not from anything the creator actually said on camera. The caption promotes a sleep stack combination, references "no morning grogginess," and tags both DSIP (Delta Sleep-Inducing Peptide) and GLP-1 alongside the "sleepy girl" trend. That's the totality of what we have to work with.

To be fair to the creator, we can't quote them on specifics because the transcript gives us nothing. What we can evaluate is what the hashtag stack implies, and what the "sleepy girl" framing typically means in this corner of TikTok wellness content. The combination of DSIP with GLP-1 peptide context is genuinely interesting from a research standpoint, even if the caption is light on details.

Does the science back this up?

DSIP has real, if limited, research behind it. The science on it as a sleep-promoting peptide is decades old, and the findings are more complicated than TikTok captions suggest. Studies in humans are sparse, small, and inconsistent.

DSIP was first isolated in 1974 by Schoenenberger and colleagues from rabbit brain perfusate. Early research suggested it could promote slow-wave sleep and reduce sleep latency. A review by Kastin and colleagues (1981, Peptides) found mixed results across species. Human trials are scarce. A study by Schneider-Helmert (1984, Sleep) reported improved sleep quality in insomnia patients, but the sample size was tiny and methodology has been criticized. More recent work has largely stalled. The half-life of DSIP in circulation is very short, and it's unclear how much survives to cross the blood-brain barrier when administered peripherally. The GLP-1 connection is even thinner. GLP-1 receptors have been found in regions of the brain involved in sleep-wake regulation, and some users of GLP-1 receptor agonists report changes in sleep, but there is no direct clinical evidence that stacking DSIP with a GLP-1 compound produces additive sleep benefits.

What did they get wrong (or right)?

The claim of "no morning grogginess" is the most specific thing in this caption, and it's worth scrutinizing. Getting it right is possible, getting it wrong is also very possible, and the evidence doesn't clearly settle it either way.

Some proponents of DSIP argue it produces more naturalistic sleep without the hangover effect of sedative-hypnotics like benzodiazepines or antihistamine-based sleep aids. That's a plausible mechanistic argument given DSIP's proposed mode of action, which appears to modulate rather than sedate. But there are no head-to-head trials comparing DSIP to common OTC sleep aids on next-day grogginess as an outcome. The absence of grogginess could also reflect that nothing sufficiently sedating happened in the first place. Without objective sleep architecture data, an anecdote about feeling fine in the morning is just that. On the GLP-1 angle, there's emerging but early data suggesting GLP-1 receptor activity may influence hypothalamic sleep circuits (Trapp et al., 2023, Nature Metabolism), but calling this a sleep stack with GLP-1 is getting ahead of the research.

What should you actually know?

If you're seeing DSIP content on TikTok and wondering whether to try it, here's what the data actually supports. DSIP is a bioactive peptide with a plausible mechanism, a few small positive human trials, and a lot of unanswered questions about bioavailability, dosing, and long-term safety.

The "sleepy girl" mocktail trend that this caption is riffing on typically refers to magnesium glycinate and tart cherry juice, which have stronger and more consistent evidence behind them for sleep support than DSIP does. Magnesium's role in sleep regulation is supported by multiple randomized controlled trials (Abbasi et al., 2012, Journal of Research in Medical Sciences). DSIP is not in that league yet. The peptide is also not FDA-approved for any indication and is used in research and compounding contexts only. Anyone sourcing DSIP should understand they are operating in an area with meaningful regulatory uncertainty and limited clinical guidance. Stacking it with GLP-1 compounds without medical supervision compounds that uncertainty significantly.